Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Von Herrath

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
Pediatric Diabetes|December 17, 2004
Islet regeneration needed for overcoming autoimmune destruction - considerations on the pathogenesis of type 1 diabetesMatthias von Herrath, Dirk Homann
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2021
How benign autoimmunity becomes detrimental in type 1 diabetesMatthias von Herrath, Ezio Bonifacio
Expert Review of Clinical Immunology|May 19, 2010
Immunoinformatics: an overview of computational tools and techniques for understanding immune functionMatthias von Herrath, Paul Taylor
Acta Diabetologica|December 1, 2017
The shifting paradigm of a "cure" for type 1 diabetes: is technology replacing immune-based therapies?Jeremy Pettus, Matthias Von Herrath
Trends in Immunology|October 14, 2003
Introducing baselines for therapeutic use of regulatory T cells and cytokines in autoimmunityMatthias von Herrath, Dirk Homann
Trends in Immunology|May 19, 2019
Regulatory Immune Mechanisms beyond Regulatory T CellsGustaf Christoffersson, Matthias von Herrath
Diabetes Care|October 2, 2009
Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedsideDamien Bresson, Matthias von Herrath
Nature Medicine|June 1, 2004
Tolerance tag teamMatthias von Herrath, Dirk Homann
Novartis Foundation Symposium|February 11, 2009
Resuscitating adaptive Tregs with combination therapies?Damien Bresson, Matthias von Herrath
The Journal of Clinical Investigation|May 8, 2009
How can we improve the translational landscape for a faster cure of type 1 diabetes?Matthias von Herrath, Andrew Chan
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Pediatric Diabetes|December 17, 2004
Islet regeneration needed for overcoming autoimmune destruction - considerations on the pathogenesis of type 1 diabetesMatthias von Herrath, Dirk Homann
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2021
How benign autoimmunity becomes detrimental in type 1 diabetesMatthias von Herrath, Ezio Bonifacio
Expert Review of Clinical Immunology|May 19, 2010
Immunoinformatics: an overview of computational tools and techniques for understanding immune functionMatthias von Herrath, Paul Taylor
Acta Diabetologica|December 1, 2017
The shifting paradigm of a "cure" for type 1 diabetes: is technology replacing immune-based therapies?Jeremy Pettus, Matthias Von Herrath
Trends in Immunology|October 14, 2003
Introducing baselines for therapeutic use of regulatory T cells and cytokines in autoimmunityMatthias von Herrath, Dirk Homann
Trends in Immunology|May 19, 2019
Regulatory Immune Mechanisms beyond Regulatory T CellsGustaf Christoffersson, Matthias von Herrath
Diabetes Care|October 2, 2009
Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedsideDamien Bresson, Matthias von Herrath
Nature Medicine|June 1, 2004
Tolerance tag teamMatthias von Herrath, Dirk Homann
Novartis Foundation Symposium|February 11, 2009
Resuscitating adaptive Tregs with combination therapies?Damien Bresson, Matthias von Herrath
The Journal of Clinical Investigation|May 8, 2009
How can we improve the translational landscape for a faster cure of type 1 diabetes?Matthias von Herrath, Andrew Chan
Pageof 14